Dabigatran vs Nivolumab

## Dabigatran vs Nivolumab: Overview

This comparison examines the pharmacological differences between **Dabigatran** and **Nivolumab**.

## Mechanism of Action

**Dabigatran**: Direct thrombin (Factor IIa) inhibitor.

**Nivolumab**: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

## Pharmacokinetics

**Half-life**: Dabigatran — 12-17 hours; Nivolumab — 27 days.

## Chemical Properties

**Molecular Formula**: Dabigatran — C25H25N7O3; Nivolumab — N/A.

**Molecular Weight**: Dabigatran — 471.5100 g/mol; Nivolumab — N/A.

**Type**: Dabigatran — Small molecule; Nivolumab — Antibody.